PAPER Mathis CA, Klunk WE
SEARCH RESULTS
330026 RESULTS
PAPER Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR, Trojanowski JQ, Lee VM, Ono M, Masamoto K, Takano H, Sahara N, Iwata N, Okamura N, Furumoto S, Kudo Y, Chang Q, Saido TC, Takashima A, Lewis J, Jang MK, Aoki I, Ito H, Higuchi M
Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.
Neuron. 2013 Sep 18;79(6):1094-108. PubMed: 24050400PAPER Clavaguera F, Grueninger F, Tolnay M
Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies.
Neuropharmacology. 2014 Jan;76 Pt A:9-15. PubMed: 24050961PAPER Yonezawa S, Fujiwara K, Yamamoto T, Hattori K, Yamakawa H, Muto C, Hosono M, Tanaka Y, Nakano T, Takemoto H, Arisawa M, Shuto S
Conformational restriction approach to β-secretase (BACE1) inhibitors III: Effective investigation of the binding mode by combinational use of X-ray analysis, isothermal titration calorimetry and theoretical calculations.
Bioorg Med Chem. 2013 Nov 1;21(21):6506-22. PubMed: 24051074PAPER Eckert A, Nisbet R, Grimm A, Götz J
March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease.
Biochim Biophys Acta. 2014 Aug;1842(8):1258-66. Epub 2013 Sep 17 PubMed: 24051203PAPER Rosenbaum R, Zimnik A, Zheng F, Turner RS, Alzheimer C, Doiron B, Rubin JE
Axonal and synaptic failure suppress the transfer of firing rate oscillations, synchrony and information during high frequency deep brain stimulation.
Neurobiol Dis. 2013 Sep 16;62C:86-99. PubMed: 24051279PAPER Antoniou M, Gunasekera GM, Wong PC
Foreign language training as cognitive therapy for age-related cognitive decline: A hypothesis for future research.
Neurosci Biobehav Rev. 2013 Sep 16; PubMed: 24051310PAPER Zhang Y, Zhang J, Hsu J, Oishi K, Faria AV, Albert M, Miller MI, Mori S
Evaluation of group-specific, whole-brain atlas generation using Volume-based Template Estimation (VTE): Application to normal and Alzheimer's populations.
Neuroimage. 2014 Jan;84:406-19. PubMed: 24051356PAPER Melancon BJ, Tarr JC, Panarese JD, Wood MR, Lindsley CW
Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease.
Drug Discov Today. 2013 Sep 17; PubMed: 24051397PAPER Rosania K
Alzheimer's disease linked to brain copper buildup.
Lab Anim (NY). 2013 Oct;42(10):346. PubMed: 24051629PAPER Horner AE, Heath CJ, Hvoslef-Eide M, Kent BA, Kim CH, Nilsson SR, Alsiö J, Oomen CA, Holmes A, Saksida LM, Bussey TJ
The touchscreen operant platform for testing learning and memory in rats and mice.
Nat Protoc. 2013 Oct;8(10):1961-84. PubMed: 24051959PAPER McGeer PL, McGeer EG
The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
Acta Neuropathol. 2013 Oct;126(4):479-97. Epub 2013 Sep 20 PubMed: 24052108PAPER Zhu L, Zhong M, Zhao J, Rhee H, Caesar I, Knight EM, Volpicelli-Daley L, Bustos V, Netzer W, Liu L, Lucast L, Ehrlich ME, Robakis NK, Gandy SE, Cai D
Reduction of synaptojanin 1 accelerates Aβ clearance and attenuates cognitive deterioration in an Alzheimer mouse model.
J Biol Chem. 2013 Nov 1;288(44):32050-63. PubMed: 24052255PAPER Benilova I, De Strooper B
Neuroscience. Promiscuous Alzheimer's amyloid: yet another partner.
Science. 2013 Sep 20;341(6152):1354-5. PubMed: 24052299PAPER Kim T, Vidal GS, Djurisic M, William CM, Birnbaum ME, Garcia KC, Hyman BT, Shatz CJ
Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model.
Science. 2013 Sep 20;341(6152):1399-404. PubMed: 24052308Current Filters
No filters selected